Dextran in Medical Devices: Enabling the Next Generation of Functional Biomaterials

From Established Material to Functional Component

Dextran has long been valued for its biocompatibility, non-toxicity, and water solubility. These intrinsic properties make it particularly suitable for applications involving direct contact with biological environments.

However, recent advances in material science have expanded its role significantly. Through chemical modification and formulation strategies, dextran can now be tailored to meet specific functional requirements in medical devices.

This shift is driving its use in:

• Surface coatings for improved hemocompatibility

• Hydrogels for tissue-contacting applications

• Controlled-release systems

• Biointerfaces in sensitive environments

What’s New: Emerging Applications in Medical Devices with Dextran

Recent research highlights how dextran is increasingly used in advanced device design:

• Surface Coatings and Anti-Fouling Layers

Dextran-based coatings are being explored to reduce protein adsorption and improve hemocompatibility, particularly in devices exposed to blood or biological fluids.

• Hydrogels and Tissue-Interfacing Materials

Dextran-based hydrogels are widely used in biomedical applications due to their ability to retain water and mimic biological environments.
These materials are particularly relevant for wound care, regenerative medicine, and implantable devices.

• Drug-Eluting and Controlled Release Devices

Dextran is increasingly used as a carrier in drug delivery systems, including nanoparticles, hydrogels, and bio-conjugates, enabling controlled and targeted release.

• Injectable and Minimally Invasive Systems

Modified dextrans allow the design of injectable systems with tunable degradation and mechanical properties, supporting next-generation medical devices.

The Role of Dextran in Device Performance

In modern medical devices, dextran contributes to:

• Biocompatibility → reducing adverse biological reactions

• Surface functionality → controlling protein and cell interactions

• Material flexibility → enabling tailored properties through modification

• Stability and reproducibility → critical for regulatory approval

As highlighted in recent reviews, dextran’s versatility stems from its modifiable structure and compatibility with other materials, allowing it to be adapted to a wide range of biomedical applications.

Why Material Quality Matters

As dextran becomes a functional component rather than a background material, quality becomes a critical factor.

Key considerations include:

• Consistent molecular weight distribution

• Controlled substitution and modification

• Batch-to-batch reproducibility

• Traceability and regulatory compliance

Lower-quality materials can introduce variability that directly impacts:

• device performance

• reproducibility

• regulatory outcomes

Conclusion: A Material Enabling Innovation

Dextran is no longer just a legacy biomaterial.

It is increasingly a key enabler of innovation in medical devices, supporting performance, reproducibility, and scalability.

As device complexity increases, so does the importance of selecting materials that can support both scientific performance and regulatory success.

References

1. Luanda, A. et al. Past, present and future of biomedical applications of dextran-based hydrogels: A review, International Journal of Biological Macromolecules, 2023; Vol 228: 794-807, https://doi.org/10.1016/j.ijbiomac.2022.12.129

2. Petrovici, AR. et al. Dextran Formulations as Effective Delivery Systems of Therapeutic Agents. Molecules, 2023; Vol 28(3):1086, https://doi.org/10.3390/molecules28031086.

3. Wagh, H. et al. Comprehensive investigation of synthesis, properties and biomedical utilization of multifunctional dextran-based polymeric nanoparticles. Colloid Polym Sci, 2026; Vol 304: 735–761, https://doi.org/10.1007/s00396-025-05552-y

4. Zhao, Y. et al. Dextran, as a biological macromolecule for the development of bioactive wound dressing materials: A review of recent progress and future perspectives, International Journal of Biological Macromolecules, 2022; Vol 207: 666-682, https://doi.org/10.1016/j.ijbiomac.2022.02.114